Why Twist Bioscience Corporation (TWST) stock moved
Updated Oct 26, 2026
Twist Bioscience Corporation (TWST) shares rose 3.3% to $139.92 as of October 26, 2026, a moderate gain from the prior close of $135.47. BestStocks flagged the session as a major change for TWST. The move is tied to price move up. Below, we break down what changed for TWST, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
What happened
TWST climbed 3.3% to $139.92
TWST rose 3.3% in its latest session, moving from $135.47 to $139.92.
Material / EarningsLow confidence
Rel. volume
0.9×
Below Avg
Vs peers
—
No comparable peers
Market cap
$9.2B
NASDAQ Global Select
Analyst target
$154
+9.8% vs price
Price chart
Sep 25 – Oct 26
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details
What it means for Twist Bioscience Corporation investors
For Twist Bioscience Corporation investors, the balance of recent signals points to a bullish shift. On the constructive side: Material positive event; Positive 3.3% session move. Wall Street's consensus price target sits at $153.70, implying +9.8% upside from $139.92. BestStocks rates the overall signal quality low (49/100). With earnings roughly 18 days out, the next report is the most likely near-term test of the move.
TWST price reaction
TWST last traded at $139.92, up $4.45 (+3.28%) from the previous close of $135.47. The session traded on 0.9× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $132.75 and $205.00, and it currently sits about 10% of the way up that band.
Bullish and bearish analyst opinions on Twist Bioscience Corporation (TWST)
The consensus analyst price target on Twist Bioscience Corporation (TWST) is $153.70, 9.8% above the recent $139.92. Over the past 90 days analysts logged 0 upgrades, 9 maintains, and 0 downgrades. Here is how the bullish and bearish cases on TWST line up.
▲ The bullish case
+Wall Street's consensus price target of $153.70 implies +9.8% upside from $139.92.
+The Street's most bullish target is $215.00 (+53.7%).
+Material positive event.
+Positive 3.3% session move.
+Positive price momentum.
▼ The bearish case
−The most bearish analyst target is $89.00 (-36.4%).
Bull vs bear balanceBullish Shift
BearishNeutralBullish
Weighing both sides, BestStocks' composite read of recent signals is bullish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Oct 26, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Twist Bioscience Corporation (TWST) moved -6.02% from $144.00 to $135.34 on 2026-10-22. No company-specific catalyst was found. The decline was driven by a broader pullback in high-beta synthetic biology and biotech names, combined with technical profit-taking following the stock's multi-month run-up toward its 52-week high of $219.71.
Material / Earnings2026-10-21+4.5%
Twist Bioscience Corporation (TWST) moved +7.87% from $138.25 to $149.13 on 2026-10-21. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was near its 5-day average, suggesting the move was not driven by unusual trading activity.
Twist Bioscience Corporation moved +6.53% intraday from $132.75 to $141.43. Twist Bioscience Corp (NASDAQ: TWST ) is up over 6% today, trading around $141.40. - Positive Momentum & Analyst Support: The stock is rebounding from recent volatility, supported by favorable analyst sentiment (such as TD Cowen raising its price target to $190 in mid-October) and ongoing interest in the company's picks-and-shovels role in AI-enabled drug discovery and synthetic DNA synthesis. - Recovery from Recent Pullbacks: TWST experienced choppy trading and profit-taking earlier in the month following a high near the $219 range, and today's session is seeing renewed buyer interest after a recent series of regulatory Form 144 filings. - Fundamental Growth: The upward movement aligns with the company's recent strong fiscal third-quarter report, which featured 23% year-over-year revenue growth and expanding gross margins driven by its semiconductor-based DNA platform. If you'd like, I can: - Summarize Twist Bioscience's upcoming earnings date (November 13, 2026) - Break down their latest Q3 financial metrics - Look at recent insider trading or institutional activity Which of those would you like to explore?
Material / Earnings2026-10-16-8.1%
TWST moved -7.74% from its $143.88 open to a $132.75 close on 2026-10-16.
Twist Bioscience shares fell 6.13% to $149.98 following profit-taking near 52-week highs compounded by sustained institutional selling and insider stock sales, per the web catalyst. ARK Invest extended a multi-week divestment across its funds (ARKK, ARKG), while executives including CEO Emily Leproust and CAO Robert Werner recently sold blocks of stock. Valuation concerns have also weighed on sentiment, with the stock cited as roughly 42.9% overvalued relative to fair value estimates (Investing.com). Volume of 894,410 shares at 130 minutes into the session tracked 0.85x the historical average—normal for this time of day.
Twist Bioscience rose 6.05% to $161.25 amid normal intraday volume (1.50x historical average). No specific catalyst was identified in today's news flow—recent headlines show routine executive share sales (SVP, president, and other insiders sold between $27k–$111k each) rather than material company developments. The move appears driven by broad market or sector momentum rather than company-specific news.
Material / Earnings2026-10-06-18.6%
Twist Bioscience Corporation (TWST) moved -20.32% from $209.55 to $166.97 on 2026-10-06. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move occurred on elevated volume (2.6x the 5-day average), suggesting institutional selling pressure.
Material / Earnings2026-10-05+8.7%
Twist Bioscience Corporation (TWST) moved +7.91% from $189.97 to $205.00 on 2026-10-05, reaching a new 30-day high. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found.
In-depth TWST event analyses
Permanent, dated analyses of TWST's most significant sessions.
Why did Twist Bioscience Corporation (TWST) stock move?
TWST rose 3.3% to $139.92. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did TWST stock rise?
TWST gained 3.28% ($4.45) versus the prior close of $135.47, last trading at $139.92 on 0.9× average volume.
When is Twist Bioscience Corporation's next earnings date?
TWST's next earnings report is estimated for 2026-11-13 — about 18 days away.
What is the analyst price target for TWST?
The consensus analyst price target for TWST is $153.70, about 9.8% above the current $139.92. Over the past 90 days, analysts recorded 0 upgrades, 9 maintains, and 0 downgrades.
How BestStocks tracks TWST
This page is generated automatically by BestStocks' change-detection system after price move up was detected and verified against independent data sources. It draws on 20 tracked change events for TWST, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of October 26, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.
